Human T-lymphotropic virus 1, a member of the Retroviridae family, causes a neglected,
silent, persistent infection affecting circa 5 to 10 million people around the world, with …

The human T-cell lymphotropic virus type 1 (HTLV-1) is an oncogenic retrovirus that is
transmitted from mother to child, particularly through prolonged breastfeeding; between …

Human T-cell leukemia virus type-1 (HTLV-1) causes two distinct diseases, adult T-cell
leukemia/lymphoma (ATL) and HTLV-1-associated myelopathy/tropical spastic paraparesis …

HTLV-1 is the etiological agent of a neurological disease named HAM/TSP that has clinical
characteristics similar to those of multiple sclerosis (MS). The PBMC obtained from …

So far, only two retroviruses, human immunodeficiency virus (HIV)(type 1 and 2) and human
T-cell lymphotropic virus type 1 (HTLV-1), have been recognized as pathogenic for humans …

Even though an estimated 10–20 million people worldwide are infected with the oncogenic
retrovirus, human T-lymphotropic virus type 1 (HTLV-1), its epidemiology is poorly …

Human T-cell leukemia virus type 1 (HTLV-1) was the first human retrovirus discovered.
Studies on HTLV-1 have been instrumental for our understanding of the molecular …

Human T cell lymphotropic virus 1 (HTLV-1) is a human retrovirus and infects approximately
10–20 million people worldwide. While the majority of infected people are asymptomatic …

The human retrovirus human T-lymphotropic virus type 1 (HTLV-1) is associated with two
distinct types of disease: the malignancy known as adult T-cell leukemia and a range of …

Background Previous studies have suggested debatable roles of Tax and HBZ gene
expression in the pathogenesis of HTLV-1-associated myelopathy/tropical spastic …